Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

This study has been completed.
Sponsor:
Information provided by:
Taro Pharmaceuticals USA
ClinicalTrials.gov Identifier:
NCT00244439
First received: October 24, 2005
Last updated: December 19, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)